CLINICAL_TRIALS
trial_result
· 2018-10-17
Clinical Trial Update: Efficacy Trial of the Implantation of Mouse Renal Adenocarcinoma Macrobeads in Subjects With Castration-Resistant Prostate Cancer Resistant to Taxanes (Docetaxel, Cabazitaxel) and Evidence of Disease Progression on Androgen-axis Inhibition and/or Immunotherapy in the Form of Sipuleucel-T [Phase 2]
Summary
Phase 2 efficacy trial evaluating implantation of mouse renal adenocarcinoma macrobeads in men with castration-resistant prostate cancer that progressed despite…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: The Rogosin Institute | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2018-10-17